A phase II study of chlorambucil + rituximab (CLB-R) followed by R maintenance vs observation in elderly patients with previously untreated chronic lymphocytic leukemia (CLL): induction phase results

FOÀ R.;ALIETTI A.;GUARINI A.;CIOLLI S.;DI RAIMONDO F.;DEL POETA G.;LAURIA F.;FORCONI F.;CUNEO A.;CORTELLEZZI A.;NOBILE F.;CALLEA V.;BRUGIATELLI M.;MASSAIA M.;MOLICA S.;TRENTIN L.;RIZZI, Rita;SPECCHIA G.;ORSUCCI L.;AMBROSETTI A.;MONTILLO M.;ZINZANI L.;FERRARA F.;MORABITO F.;MURA M.;SORIANI S.;SANTANGELO S.;MARINELLI M.;DE PROPRIIS M.;ALIETTI A.;RUNGGALDIER J.

2011-01-01